Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Prospective cohort study of patients with early gastric cancer to detect prodromal Parkinson disease (EGC-PPD): A study protocol and baseline characteristics.

Shin C, Yang HK, Park S, Lee HJ, Kong SH, Suh YS, Huh YJ, Kim YJ, Park SY, Ahn TB, Lee SH, Kim HJ, Jeon B.

J Clin Neurosci. 2019 Aug;66:26-32. doi: 10.1016/j.jocn.2019.05.033. Epub 2019 May 29.

PMID:
31153750
2.

Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.

Ferrer I, Martinez A, Blanco R, Dalfó E, Carmona M.

J Neural Transm (Vienna). 2011 May;118(5):821-39. doi: 10.1007/s00702-010-0482-8. Epub 2010 Sep 23. Review.

PMID:
20862500
3.

How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder.

Postuma RB, Lang AE, Gagnon JF, Pelletier A, Montplaisir JY.

Brain. 2012 Jun;135(Pt 6):1860-70. doi: 10.1093/brain/aws093. Epub 2012 May 4.

PMID:
22561644
4.

Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.

Beavan M, McNeill A, Proukakis C, Hughes DA, Mehta A, Schapira AH.

JAMA Neurol. 2015 Feb;72(2):201-8. doi: 10.1001/jamaneurol.2014.2950.

5.

Prevalence of Prodromal Parkinson's Disease as Defined by MDS Research Criteria among Elderly Patients Undergoing Colonoscopy.

Skorvanek M, Ladomirjakova Z, Han V, Lesko N, Feketeova E, Jarcuskova D, Repkova B, Spisak P, Urbancikova Z, Vargova A, Gombosova L, Zakuciova M, Veseliny E, Trebuna F, Mechirova E, Gdovinova Z.

J Parkinsons Dis. 2017;7(3):481-489. doi: 10.3233/JPD-161036.

PMID:
28387681
6.

Motor function and the probability of prodromal Parkinson's disease in older adults.

Maraki MI, Stefanis L, Yannakoulia M, Kosmidis MH, Xiromerisiou G, Dardiotis E, Hadjigeorgiou GM, Sakka P, Scarmeas N, Stamelou M.

Mov Disord. 2019 Jul 17. doi: 10.1002/mds.27792. [Epub ahead of print]

PMID:
31314148
7.

Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts.

Pilotto A, Heinzel S, Suenkel U, Lerche S, Brockmann K, Roeben B, Schaeffer E, Wurster I, Yilmaz R, Liepelt-Scarfone I, von Thaler AK, Metzger FG, Eschweiler GW, Postuma RB, Maetzler W, Berg D.

Mov Disord. 2017 Jul;32(7):1025-1034. doi: 10.1002/mds.27035. Epub 2017 May 16.

PMID:
28509336
8.

Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Cohort.

Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, Marek K; PARS Investigators.

JAMA Neurol. 2017 Aug 1;74(8):933-940. doi: 10.1001/jamaneurol.2017.0985.

9.

Frequency and profile of Parkinson's disease prodromi in patients with malignant melanoma.

Walter U, Heilmann E, Voss J, Riedel K, Zhivov A, Schäd SG, Gross GE, Benecke R, Trcka J.

J Neurol Neurosurg Psychiatry. 2016 Mar;87(3):302-10. doi: 10.1136/jnnp-2014-310239. Epub 2015 Mar 27.

PMID:
25817520
10.

Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.

Walter U, Dressler D, Probst T, Wolters A, Abu-Mugheisib M, Wittstock M, Benecke R.

Arch Neurol. 2007 Nov;64(11):1635-40.

PMID:
17998447
11.

Variation in Recent Onset Parkinson's Disease: Implications for Prodromal Detection.

Swallow DM, Lawton MA, Grosset KA, Malek N, Smith CR, Bajaj NP, Barker RA, Ben-Shlomo Y, Burn DJ, Foltynie T, Hardy J, Morris HR, Williams N, Wood NW, Grosset DG; PRoBaND Clinical Consortium.

J Parkinsons Dis. 2016 Mar 19;6(2):289-300. doi: 10.3233/JPD-150741.

12.

Screening for prodromal Parkinson's disease in the general community: a sleep-based approach.

Postuma RB, Pelletier A, Berg D, Gagnon JF, Escudier F, Montplaisir J.

Sleep Med. 2016 May;21:101-5. doi: 10.1016/j.sleep.2015.12.016. Epub 2016 Mar 10.

PMID:
27448479
13.

Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease.

Bäckström DC, Eriksson Domellöf M, Linder J, Olsson B, Öhrfelt A, Trupp M, Zetterberg H, Blennow K, Forsgren L.

JAMA Neurol. 2015 Oct;72(10):1175-82. doi: 10.1001/jamaneurol.2015.1449.

PMID:
26258692
14.

Biomarkers in Prodromal Parkinson Disease: a Qualitative Review.

Cooper CA, Chahine LM.

J Int Neuropsychol Soc. 2016 Nov;22(10):956-967. Review.

PMID:
27903331
15.

Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.

Wilson H, Dervenoulas G, Pagano G, Koros C, Yousaf T, Picillo M, Polychronis S, Simitsi A, Giordano B, Chappell Z, Corcoran B, Stamelou M, Gunn RN, Pellecchia MT, Rabiner EA, Barone P, Stefanis L, Politis M.

Lancet Neurol. 2019 Aug;18(8):748-759. doi: 10.1016/S1474-4422(19)30140-1. Epub 2019 Jun 19.

PMID:
31229470
16.

Progression of prodromal motor and non-motor symptoms in the premotor phase study - 2-year follow-up data.

Liepelt-Scarfone I, Brändle B, Yilmaz R, Gauss K, Schaeffer E, Timmers M, Wurster I, Brockmann K, Maetzler W, Van Nueten L, Streffer JR, Berg D.

Eur J Neurol. 2017 Nov;24(11):1369-1374. doi: 10.1111/ene.13397. Epub 2017 Sep 5.

PMID:
28872736
17.

Association Between Poor Cognitive Functioning and Risk of Incident Parkinsonism: The Rotterdam Study.

Darweesh SKL, Wolters FJ, Postuma RB, Stricker BH, Hofman A, Koudstaal PJ, Ikram MK, Ikram MA.

JAMA Neurol. 2017 Dec 1;74(12):1431-1438. doi: 10.1001/jamaneurol.2017.2248.

18.

Advances in markers of prodromal Parkinson disease.

Postuma RB, Berg D.

Nat Rev Neurol. 2016 Oct 27;12(11):622-634. doi: 10.1038/nrneurol.2016.152. Review.

PMID:
27786242
19.

Parkinson's Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism.

van Rumund A, Aerts MB, Esselink RAJ, Meijer FJA, Verbeek MM, Bloem BR.

BMC Neurol. 2018 May 16;18(1):69. doi: 10.1186/s12883-018-1072-x.

20.

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.

Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Döring F, Trenkwalder C, Schlossmacher MG.

Lancet Neurol. 2011 Mar;10(3):230-40. doi: 10.1016/S1474-4422(11)70014-X. Erratum in: Lancet Neurol. 2011 Apr;10(4):297.

PMID:
21317042

Supplemental Content

Support Center